NCT06665035View on ClinicalTrials.gov

A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

PHASE3RecruitingINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

March 3, 2030

Study Completion Date

March 3, 2030

Conditions
Dengue Fever
Interventions
BIOLOGICAL

TDV

TDV SC injection.

OTHER

Placebo

Placebo SC injection.

Trial Locations (4)

10330

NOT_YET_RECRUITING

King Chulalongkorn Memorial Hospital, Pathum Wan

12120

RECRUITING

Thammasat University Hospital, Khlong Luang

80020

NOT_YET_RECRUITING

Clinica de la Costa Ltda, Barranquilla

760042

NOT_YET_RECRUITING

Centro de Estudios en Infectologia Pediatrica S.A.S, Santiago de Cali

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY